Date Name Title Filing Type Shares Traded Price Total Held
Dec 08, 2009
Director
Director Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 187,500 -- --
Dec 17, 2008
Director, President & CEO
Director, President & CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 187,500 -- 312,500
Oct 30, 2015
Director, President Regeneron Laboratori
Director, President Regeneron Laboratori Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 182,818 $11.64 682,818
Oct 30, 2015
Director, President Regeneron Laboratori
Director, President Regeneron Laboratori Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 182,818 -- --
Dec 19, 2005
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 182,818 -- 182,818
Jun 14, 2005
Director
Director Form 4 Other acquisition or disposition (describe transaction) 182,171 -- 339,396
Jun 14, 2005
Director
Director Form 4 Other acquisition or disposition (describe transaction) 182,171 -- 63,511
Aug 03, 2017
Director, President and CSO
Director, President and CSO Form 4 Bona fide gift 176,223 -- 176,223
Aug 03, 2017
Director, President and CSO
Director, President and CSO Form 4 Bona fide gift 176,223 -- 155,406
Jul 21, 2017
Director, President and CSO
Director, President and CSO Form 4 Bona fide gift 176,223 -- 323,777

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.